Podcast

Something Fresh in the State of Denmark

October 06, 2026
Go
cornell tech sign on the jacobs technion cornell institute campus during awards ceremony at cornell tech on roosevelt island, nyc | Donate to Support Israel | Technion University
In The News

The Runway Startup Program Welcomes Its Newest Founders

October 05, 2026
Go
cultivated meat
In The News

How Cultivated Meat Went From the Lab to the Plate

October 05, 2026
Go
Video

Why the Perfect Pitch is Your Biggest Mistake

September 23, 2026
Go
technion prof Marcelle Machluf, foodtech researcher, in a lab wearing a white coat with instruments in background | Donate to Support Israel | Technion University
Video

Harnessing Science and Entrepreneurship to Battle Cancer

November 03, 2026
Go
personalized nutrition
Article

One Diet Doesn’t Fit All: Digesting the Difference Between Men and Women

October 29, 2026
Go
Jewish Philanthropy | American Technion Society | Donate to Israel
In The News

A Clearer Choice: How AI Could Guide Breast Cancer Treatment

October 28, 2026
Go
Article

From the Lab to the Patient’s Bedside 

October 20, 2026
Go
Israeli AI innovations
In The News

Israeli AI Innovations Earn Spots Among TIME’s Best Inventions of 2026

November 04, 2026
Go
to be israeli | israeli flag in window of office building | Donate to Support Israel | How to Support Technion University
In The News

The Cost of Cutting Off Genius: Why Israeli Academic Collaboration Matters

October 20, 2026
Go
Ido Kaminer, uv light for covid researcher
In The News

Faster Than Light, Without Breaking the Rules

October 20, 2026
Go
AI breast cancer treatment
Article

The AI Tool That’s Transforming Breast Cancer Treatment 

October 12, 2026
Go
to be israeli | israeli flag in window of office building | Donate to Support Israel | How to Support Technion University
In The News

The Cost of Cutting Off Genius: Why Israeli Academic Collaboration Matters

October 20, 2026
Go
back of the head of an IDF soldier with Israeli flag and blue graphic | managing | Donate to Israel | Technion University
Video

October 7 Changed His Life. The Technion Helped Him Rebuild It.

October 09, 2026
Go
strength in every step | American Technion Society | Donate to Israel
Article

Strength in Every Step: Recovery, Resilience, and a Walk to Remember

August 21, 2026
Go
Student Resilience | American Technion Society | Donate to Israel
Article

Never Too Late for a New Challenge

August 17, 2026
Go
Reuven Aronashvili
Video

From a Poor Town to Leading Paradigms in Cyber

September 25, 2026
Go
earthquake rescue | American Technion Society | Donate to Israel
In The News

Israeli Drones Aid Earthquake Rescue Efforts in Venezuela

July 08, 2026
Go
No GPS or Communication Drones flying in the background as a soldier's shadowy silhouette fills the foreground
Video

When GPS Fails, This Drone Keeps Going

June 10, 2026
Go
Article

Technion Innovations: Safeguarding Israel and the World

May 28, 2026
Go
Article

From Technion Student to Technion Professor

October 06, 2026
Go
Article

Seeds of a New Community

September 08, 2026
Go
Tree Canopy | American Technion Society | Donate to Israel
In The News

Cornell Tech’s Tree Canopy Project Builds a Cooler New York City

August 11, 2026
Go
Wildfire detection | American Technion Society | Donate to Israel
In The News

Wildfire Detection Takes Flight With AI-Powered Drones

August 04, 2026
Go
2024 - technion campus
In The News

Shaping the AI Future Starts in the Classroom

October 26, 2026
Go
Israel Flag
Video

The Technion: Building Israel, Shaping Tomorrow 

October 09, 2026
Go
In The News

What Becomes Possible Next?

October 07, 2026
Go
genetic evolution
Article

Tiny DNA Tweaks, Big Evolutionary Changes 

October 07, 2026
Go
IDF soldiers in the background of an israeli flag with a blue graphic | Donate to Israel | Support the Technion
Video

A Technion Connection Generations in the Making

November 05, 2026
Go
Jewish Philanthropy | American Technion Society | Donate to Israel
In The News

A Clearer Choice: How AI Could Guide Breast Cancer Treatment

October 28, 2026
Go
israeli flag and technion flag flying in front of rappaport building in haifa, israel | Donate to Support Israel | Technion University | American Technion Society
Video

The Gift That Keeps On Giving

October 23, 2026
Go
Video

An Unexpected Invitation

October 23, 2026
Go

Watch, Read & Listen

Explore stories, news, insights, and data across articles, videos, and podcasts.

view all content types
personalized nutrition
Article

One Diet Doesn’t Fit All: Digesting the Difference Between Men and Women

October 29, 2026
Go
Article

From the Lab to the Patient’s Bedside 

October 20, 2026
Go
Healthy Aging Research
Article

Grand Gestures

October 12, 2026
Go
AI breast cancer treatment
Article

The AI Tool That’s Transforming Breast Cancer Treatment 

October 12, 2026
Go
IDF soldiers in the background of an israeli flag with a blue graphic | Donate to Israel | Support the Technion
Video

A Technion Connection Generations in the Making

November 05, 2026
Go
technion prof Marcelle Machluf, foodtech researcher, in a lab wearing a white coat with instruments in background | Donate to Support Israel | Technion University
Video

Harnessing Science and Entrepreneurship to Battle Cancer

November 03, 2026
Go
israeli flag and technion flag flying in front of rappaport building in haifa, israel | Donate to Support Israel | Technion University | American Technion Society
Video

The Gift That Keeps On Giving

October 23, 2026
Go
Video

An Unexpected Invitation

October 23, 2026
Go
Podcast

Something Fresh in the State of Denmark

October 06, 2026
Go
Podcast

Predictions from The Himalayas

September 17, 2026
Go
Podcast

Everything In-House

August 11, 2026
Go
the heart | American Technion Society | Donate to Israel
Podcast

The Heart Will Go On

July 15, 2026
Go
Israeli AI innovations
In The News

Israeli AI Innovations Earn Spots Among TIME’s Best Inventions of 2026

November 04, 2026
Go
Jewish Philanthropy | American Technion Society | Donate to Israel
In The News

A Clearer Choice: How AI Could Guide Breast Cancer Treatment

October 28, 2026
Go
2024 - technion campus
In The News

Shaping the AI Future Starts in the Classroom

October 26, 2026
Go
to be israeli | israeli flag in window of office building | Donate to Support Israel | How to Support Technion University
In The News

The Cost of Cutting Off Genius: Why Israeli Academic Collaboration Matters

October 20, 2026
Go
16K +

students

3

countries

43 %

of the student body are women

The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.

About ATS

ATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.

Learn More

About the Technion

For more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.

Learn More

Lose Weight Without Drugs or Side Effects

white scale and yellow measuring tape against a white background to lose weight | Donate to Israel | Support the Technion University

What does it take to achieve a slender physique? In years past, individuals seeking to lose weight needed to spend hours sweating at the gym or subject themselves to chalky meal replacement shakes. Today, there is an easier way, found through a doctor’s prescription pad.

A Technion alumnus has developed a medical solution that rivals injectable drugs like Ozempic but has fewer downsides: a weight loss pill known as Epitomee. The pill was developed by a company of the same name (opens in a new tab) and approved by the FDA in September 2024. It is expected to become available in the U.S. next fall.

“Its innovative approach offers a safe and effective option for patients,” said Shimon Eckhouse, Ph.D., Epitomee co-founder, chairman of the board, and Technion alumnus, in a company press release. “The ability to manage weight through a simple, drug-free capsule opens up new possibilities for those seeking to improve their health and quality of life.”

How Epitomee Works

Unlike injectable weight loss drugs, whose active ingredients are semaglutide (as in Ozempic and Wegovy) or tirzepatide (as in Mounjaro), the pill does not contain any active substance but instead achieves its effects through an innovative design. Once swallowed, the pill expands to form a rigid triangle, mimicking the presence of food and triggering the sensation of satiety. The device remains in the stomach for several hours before passing into the intestines, where it disintegrates. Patients are instructed to ingest the pill twice daily before meals, reducing their appetite during mealtimes.

The key to the pill’s design lies in tiny grains of polymers inside the pill. The polymers absorb water and other liquids from the stomach, inflating to 100 times their original size. Once the device reaches the intestines, the changing pH environment causes the device to dissolve, and the remnants are excreted naturally.

Proven Results — With Distinct Advantages

Prior to FDA approval, Epitomee was tested in a U.S.-based study that demonstrated strong efficacy and tolerability. In the RESET study, a cohort of 279 overweight and obese adults was asked to take one capsule of the weight loss pill or a placebo twice daily, alongside diet and exercise, for 24 weeks. Of the subjects who received the weight loss pill, 55.5% reduced their total body weight by at least 5%. Epitomee treatment was well tolerated, with fewer patient dropouts in the Epitomee group than in the control group. Additionally, no serious adverse device effects were reported in the study.

Epitomee has several advantages over injectable weight loss drugs like Ozempic, Wegovy, and Mounjaro. The active ingredients in these drugs work by stimulating receptors throughout the body to suppress appetite and lower blood sugar. Their effects are potent, with users experiencing an overall body weight loss of 15% to 20%. However, side effects are numerous and commonly include gastrointestinal issues like nausea, vomiting, diarrhea, stomach pain, and constipation. Patients also risk more serious side effects, such as pancreatitis, gallbladder problems, vision changes, and thyroid tumors, among others.

Though no adverse effects were reported in the RESET study, if Epitomee users do experience unwanted effects, they can immediately discontinue use of the pill, and the effects will diminish after just a few hours. The effects of a weekly injection take longer to wear off. And swallowing a pill, unlike receiving an injection, is painless.

Potential Rivals

Epitomee may eventually face new rivals: Danish pharmaceutical company Novo Nordisk, the maker of Ozempic and Wegovy, and U.S.-based Eli Lilly, the maker of Mounjaro, are both working on orally administered weight loss pills containing the same or similar active ingredients as those in injectable weight loss drugs.

Nevertheless, Epitomee will maintain the advantage of being a drug-free option, free of serious side effects — true to its name, the epitome of a miracle drug.

Related Stories

technion prof Marcelle Machluf, foodtech researcher, in a lab wearing a white coat with instruments in background | Donate to Support Israel | Technion University
Video

Harnessing Science and Entrepreneurship to Battle Cancer

November 03, 2026

Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]

Go
personalized nutrition
Article

One Diet Doesn’t Fit All: Digesting the Difference Between Men and Women

October 29, 2026

Can the future of nutrition be more personalized, even down to our biology? A new study from the Technion suggests it can.  Researchers in the Faculty of Biotechnology and Food Engineering recently discovered that men and women digest milk and plant-based milk alternatives differently — a breakthrough that could have far-reaching implications for nutrition science, […]

Go
Jewish Philanthropy | American Technion Society | Donate to Israel
In The News

A Clearer Choice: How AI Could Guide Breast Cancer Treatment

October 28, 2026

This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]

Go

Love Israel and Science? 

Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.

Secret Link
Albert AI may make mistakes.